Michael Houghton

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source:ualberta.ca

Michael Houghton, PhD, is a Professor at the Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada. He was the first to successfully identify and clone the Hepatitis C virus.[1] His professional interests are the Hepatitis C virus, the Hepatitis B virus, and exploring if other chronic illnesses are caused or exacerbated by an acute or persistent viral infection.[2]

Dr. Houghton and his virology team are working on a biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) using diagnostic cytokine patterns (specifically circulating interleukin (IL)-16, IL-7, and Vascular Endothelial Growth Factor A (VEGF-A).[3] The team is also investigating if a novel pathogen is associated with a cluster of CFS patients.[4]

Awards[edit | edit source]

  • Canada Excellence Research Chair in Virology at the University of Alberta[5]
  • 2000, Albert Lasker Clinical Medical Research Award[6]

Chronic Fatigue Syndrome Advisory Committee[edit | edit source]

Dr. Houghton served as a voting member of the Chronic Fatigue Syndrome Advisory Committee from 05/10/10 to 05/10/14.[7]

Notable studies[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]


References[edit | edit source]

  1. http://www.cerc.gc.ca/chairholders-titulaires/houghton-eng.aspx
  2. http://www.mmi.med.ualberta.ca/staff_students/michael_houghton.php
  3. 3.03.1 Landi, Abdolamir; Broadhurst, David; Vernon, Suzanne D.; Tyrrell, D. Lorne J.; Houghton, Michael (Feb 2016). "Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome". Cytokine. 78: 27–36. doi:10.1016/j.cyto.2015.11.018. 
  4. http://solvecfs.org/research/cfidsaa-research-program-for-researchers/michael-houghton/
  5. http://www.mmi.med.ualberta.ca/staff_students/michael_houghton.php
  6. http://www.laskerfoundation.org/awards/
  7. HHS.gov (2010), October 12 & 13, 2010 CFSAC Meeting (PDF) (Roster) 
  8. Steffen, Imke; Tyrrell, D. Lorne; Stein, Eleanor; Montalvo, Leilani; Lee, Tzong-Hae; Zhou, Yanchen; Lu, Kai; Switzer, William M.; Tang, Shaohua; Jia, Hongwei; Hockman, Darren; Santer, Deanna M.; Logan, Michael; Landi, Amir; Law, John; Houghton, Michael; Simmons, Graham (Nov 17, 2011). "No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome". PLoS ONE. 6 (11): e27870. doi:10.1371/journal.pone.0027870. ISSN 1932-6203. PMC 3219700Freely accessible. PMID 22114717. 
  9. Jason, LA; Unger, ER; Dimitrakoff, JD; Fagin, AP; Houghton, M; Cook, DB; Marshall, GD, Jr; Klimas, N; Snell, C (2012), "Minimum data elements for research reports on CFS", Brain, Behavior, Immunology, 26 (3): 401-6, doi:10.1016/j.bbi.2012.01.014, PMID 22306456 

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

Chronic fatigue syndrome advisory committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.

Antibody - Antibodies or immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.